Stress ulcer prophylaxis: Reducing non-indicated prescribing after hospital discharge

Annals of Pharmacotherapy

Volumn 44, Issue 10, 2010, Pages 1565-1571

  Hatch, Jacob B ^a   Schulz, Lucas ^a   Fish, Jeffrey T ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Anti ulcer agents; Critical care; Gastric bleeding; Pharmacist intervention; Stress ulcer prophylaxis

Indexed keywords

ANTIULCER AGENT; PANTOPRAZOLE; RANITIDINE; SUCRALFATE;

ADULT; ARTICLE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT TRANSPORT; PHARMACIST ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; STOMACH ACID; STRESS ULCER;

ADULT; AGED; ANTI-ULCER AGENTS; CONTINUITY OF PATIENT CARE; DRUG UTILIZATION; FEMALE; HEALTH CARE COSTS; HOSPITALS, UNIVERSITY; HUMANS; INAPPROPRIATE PRESCRIBING; INTENSIVE CARE UNITS; MALE; MEDICATION RECONCILIATION; MIDDLE AGED; PATIENT DISCHARGE; PATIENT EDUCATION AS TOPIC; PEPTIC ULCER; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; RETROSPECTIVE STUDIES; STRESS, PSYCHOLOGICAL;

EID: 77957673507     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P167     Document Type: Article

References (23)

1. Wohlt PD, Hansen LA, Fish JT. Inappropriate continuation of stress ulcer prophylactic therapy after discharge. Ann Pharmacother 2007;41:1611-6. DOI 10.1345/aph.1K227
2. American Society of Health-System Pharmacists Commission on Therapeutics. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm 1999;56:347-79.
3. Laheij R, Sturkenboom M, Hassing R, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292:1955-60.
4. Gulmez S, Holm A, Frederiksen H, et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia; a population-based case-control study. Arch Intern Med 2007;167:950-5.
5. Ephgrave K, Kleiman-Wexler R, Pfaller M, et al. Effects of sucralfate vs antacids on gastric pathogens: results of a double-blind clinical trial. Arch Surg 1998;133:251-7.
6. Dial S, Delaney J, Barkun A, et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989-95.
7. Ho P, Maddox T, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009;301:937-44.
8. Juurlink D, Gomes T, Ko D, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009;180:713-8.
9. Cook D, Fuller H, Guyatt G, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994;330:377-81.
10. Ben-Menachem T, Bruce D, Fogel R, et al. Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysis. Crit Care Med 1996;24:338-45.
11. Daley R, Rebuck J, Welage L, et al. Prevention of stress ulceration: current trends in critical care. Crit Care Med 2004;32:2008-13.
12. Zhou Y, Zhou Z, Xue J. Burns complicated with gastrointestinal hemorrhage: analysis of 70 cases. Burns 1993;19:150-2.
13. Walter S, Thorup A, Christensen U, et al. Effect of cimetidine on upper gastrointestinal bleeding after renal transplantation: a prospective study. BMJ 1994;289:1175-6.
14. Cook D, Reeve B, Guyatt G, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 1996;275:308-14.
15. Arthur-Grube R, May D. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm 2007;64:1396-400.
16. Yang Y, Lewis J, Epstein S, et al. Long term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006;296:2947-53.
17. Targownik L, Lix L, Metge C, et al. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 2008;179:319-26.
18. Murphy D, Stevens A, Ferrentino N, et al. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit. Pharmacotherapy 2008;28:968-76.
19. Janicki T, Stewart S. Stress-ulcer prophylaxis for general medical patients: a review of the evidence. J Hosp Med 2007;2:86-92.
20. Zeigler AJ, McAllen KJ, Slot MG, Barletta JF. Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis. Ann Pharmacother 2008;42:940-6. DOI: 10.1345/aph.1L123
21. Stevens A, Thomas Z. The case against stress ulcer prophylaxis in 2007. Hosp Pharm 2007;42:995-9.
22. Top 200 prescription drugs of 2005 (May 1, 2006). Pharmacy Times. www.pharmacytimes.com/issue/pharmacy/2006/2006-05/2006-05-5509 (accessed 2010 Aug 30).
23. Lamb E. Top 200 prescription drugs of 2006 (May 1, 2007). Pharmacy Times. www.pharmacytimes.com/issue/pharmacy/2007/2007-05/2007-05-6472. (accessed 2010 Aug 30).